BIODTECH, INC.
BIRMINGHAM, AL · CIK 0001316122 · Medtech · Private
An assay measuring endotoxin neutralization in human plasma as a biomarker of immune activation and disease severity
- Grants
- $979K
- 2 awards
- Sector median: 1
- Raised
- $575K
- 1 Form D · Aug 2010
- 194 months since last filing
- Contracts
- —
- No federal contracts on record
- Patents
- 6
- 0 granted · 6 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20102012201420162018
| Date | Event | Source | Amount |
|---|---|---|---|
| Private capital raised | Form D · SEC | $575,000 | |
| Federal grant | Department of Health and Human Services · Phase II · Endotoxin Neutralization as a Biomonitor for HIV Disease Progression | $501,326 | |
| Federal grant | Department of Health and Human Services · Phase II · Endotoxin Neutralization as a Biomonitor for HIV Disease Progression | $477,786 |
Federal grant · SBIR/STTRForm D · SEC
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 919 | Granite Medical, LLC | — | — |
| 920 | LungLife AI, Inc. | — | $53M |
| 921 | BIOCHIP LABS, INC. | — | — |
| 922 | BIODTECH, INC. | — | $575K |
| 923 | Innova Vascular, Inc. | — | $22M |
| 924 | AGITATED SOLUTIONS, LLC | — | $515K |
| 925 | Qardio, Inc. | — | $39M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Founders & Team
- Alan DeanDirector
- Michael PepeDirector · Executive Officer
- Ira WeissDirector · Executive Officer
Patents
- The Use Of Endotoxin Neutralization As A Biomarker For Intestinal Wall Damageapplication
- The Use Of Endotoxin Neutralization As A Biomarker For Sepsisapplication
- The Use Of Endotoxin Neutralization As A Biomarker For Intestinal Wall Damageapplication
- Enhancing Endotoxin Detectionapplication
- Enhancing Endotoxin Detectionapplication
- Enhancing Endotoxin Detectionapplication
Regulatory activity · Medtech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.